Osteoporosis risk assessment and ethnicity: Validation and comparison of 2 clinical risk stratification instruments

Journal of General Internal Medicine

Volumn 21, Issue 6, 2006, Pages 630-635

  Cass, Alvah R ^a   Shepherd, Angela J ^a   Carlson, Carol A ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Cross cultural medical issues; Diagnosis; Osteoporosis; Women's health

Indexed keywords

ACCURACY; ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CALCULATION; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; ETHNOLOGY; FAMILY MEDICINE; FEMALE; HUMAN; INSTRUMENT; MAJOR CLINICAL STUDY; MCNEMAR TEST; OSTEOPOROSIS; PERFORMANCE; POSTMENOPAUSE; QUESTIONNAIRE; RACE; RISK ASSESSMENT; SCREENING; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; STRATIFICATION; VALIDATION PROCESS;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; CLINICAL TRIALS; CROSS-SECTIONAL STUDIES; HISPANIC AMERICANS; HUMANS; MIDDLE AGED; OSTEOPOROSIS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; UNITED STATES;

EID: 33744481283     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1111/j.1525-1497.2006.00459.x     Document Type: Article

References (33)

1. Ray N, Chan J, Thamer M, Melton M. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995 : report from the National Osteoporosis Foundation. J Bone Miner Res. 1997 12 : 24 35.
2. Black D, Cummings S, Karpf D, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet. 1996 347 : 1535 41.
3. Black D, Thompson D, Bauer D, et al. Fracture risk reduction with alendronate in women with osteoporosis : the fracture intervention trial. J Clin Endocrinol Metab. 2000 85 : 4118 24.
4. Bone H, Greenspan S, McKeever C, et al. Alendronate and estrogen effects in postmenopausal women with low bone mineral density. J Clin Endocrinol Metab. 2000 85 : 720 6.
5. Downs RJ, Bell N, Ettinger M, et al. Comparison of alendronate and intranasal calcitonin for treatment of osteoporosis in postmenopausal women. J Clin Endocrinol Metab. 2000 85 : 1783 8.
6. Ensrud K, Black D, Palermo L, et al. Treatment with alendronate prevents fractures in women at highest risk : results from the fracture intervention trial. Arch Intern Med. 1997 157 : 2617 24.
7. Delmas P. Treatment of postmenopausal osteoporosis. Lancet. 2002 359 : 2018 26.
8. Hodsman A, Hanley D, Robert J. Do bisphosphonates reduce the risk of osteoporotic fractures? An evaluation of the evidence to date. Can Med Assoc J. 2002 166 : 1426 30.
9. Hosking D, Chilvers C, Christiansen C, et al. Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. N Engl J Med. 1998 338 : 485 92.
10. Epstein S. Postmenopausal osteoporosis : fracture consequences and treatment efficacy vary by skeletal site. Aging Clin Exp Res. 2000 12 : 330 41.
11. Harris S, Watts N, Genant H, et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis : a randomized controlled trial. JAMA. 1999 282 : 1344 52.
12. McClung M, Geusens P, Miller P, et al. Effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med. 2001 344 : 333 40.
13. U.S. Preventive Services Task Force. Screening for osteoporosis in postmenopausal women: recommendations and rationale. Ann Intern Med. 2002 137 : 526 8.
14. National Osteoporosis Foundation. NOF applauds USPSTF recommendations on BMD tests. NOF Press Release, September 16, 2002
15. Wanko S, Inouye L. Gender and ethnic disparities in osteoporosis risk factors and screening. J Gen Intern Med. 2003 18 Suppl 1 : 266.
16. Michaëlsson K, Bergstrom R, Mallmin H, Holmberg L, Wolk A, Ljunghall S. Screening for osteopenia and osteoporosis : selection by body composition. Osteoporos Int. 1996 6 : 120 6.
17. Lydick E, Cook K, Turpin J, Melton M, Stine R, Byrnes C. Development and validation of a simple questionnaire to facilitate identification of women likely to have low bone density. Am J Managed Care. 1998 4 : 37 48.
18. Black D, Palermo L, Pearson J, Abbott T, Johnell O. SOFSURF : a simple, useful risk factor system can identify the large majority of women with osteoporosis. Bone. 1998 23 Suppl 5 : S605.
19. Weinstein L, Ullery B, Bourguignon C. A simple system to determine who needs osteoporosis screening. Obstet Gynecol. 1999 93 Part 1 : 757 60.
20. Cadarette S, Jaglal S, Kreiger N, McIsaac W, Darlington G, Tu J. Development and validation of the osteoporosis risk assessment instrument to facilitate selection of women for bone densitometry. Can Med Assoc J. 2000 162 : 1289 94.
21. Koh L, Sedrine W, Torralba T, et al. A simple tool to identify Asian women at increased risk of osteoporosis. Osteoporos Int. 2001 12 : 699 705.
22. National Osteoporosis Foundation. Physician's Guide to Prevention and Treatment of Osteoporosis. Washington, DC : National Osteoporosis Foundation 2003.
23. World Health Organization. Assessment of Fracture Risk and its Application to Screening for Postmenopausal Osteoporosis. Geneva : World Health Organization 1994.
24. Cadarette S, Jaglal S, Murray T. et al. Evaluation of decision rules for referring women for bone densitometry by dual-energy x-ray absorptiometry. JAMA. 2001 286 : 57 63.
25. McNemar Q. Note on the sampling error of the difference between correlated proportions or percentages. Psychometrika. 1947 12 : 153 7.
26. Elashoff JD. nQuery Advisor Version 4.0 User's Guide. Los Angeles, CA : Statistical Solutions Ltd 2000.
27. Looker A, Johnston C, Wahner H, et al. Prevalence of low femoral bone density in older US women from NHANES III. J Bone Miner Res. 1995 10 : 796 802.
28. Anonymous. Osteoporosis among estrogen-deficient women - United States, 1988-1994. MMWR. 1998 47 : 969 73.
29. Looker A, Wahner H, Dunn W, et al. Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int. 1998 8 : 468 89.
30. Looker A, Orwoll E, Johnston C, et al. Prevalence of low femoral bone density in older US adults from NHANES III. J Bone Miner Res. 1997 12 : 1761 8.
31. Silverman S, Madison R. Decreased incidence of hip fracture in Hispanics, Asians, and Blacks : California hospital discharge data. Am J Public Health. 1988 78 : 1482 3.
32. Finkelstein J, Lee M, Sowers M, et al. Ethnic variation in bone density in premenopausal and early perimenopausal women : effects of anthroppometric and lifestyle factors. J Clin Endocrinol Metab. 2002 87 : 3057 67.
33. Binstock M. Osteoporosis : risk factor prevalence and drug and densitometry utilization. Obstet Gynecol. 2000 95 Suppl 4 : 50S.